Coliseum Capital Initiates 6.2% Position in Medifast Inc (MED)

Coliseum Capital, managed by Christopher Shackelton and Adam Gray, has disclosed a new 6.2% stake in Medifast Inc (NYSE:MED). The position amasses 813,800 shares of the common stock and is passive by nature.

Medifast, Inc. (NYSE:MED)

Medifast Inc (NYSE:MED) produces and distributes clinically proven, portion-controlled weight-loss products and programs. The company’s net income was $5.3 million, or $0.39 per share in the fourth quarter of 2013, compared to net income of $1.9 million, or $0.13 per share, for the comparable quarter in 2012. For the fiscal year 2013, Medifast’s net income increased $8.1 million to $24.0 million, or $1.73 per share, compared to net income of $15.9 million, or $1.16 per share last year.

On March 10, Medifast Inc (NYSE:MED) announced that it is going to expand its international presence by launching in Canada. The expansion will take place in the first quarter of 2014, and the program, at launch, will include a variety of 11 Medifast Meal Replacement foods with plans to expand the line over time.

Among the largest shareholders of Medifast is Jacob Gottlieb‘s Visium Asset Management, which in its latest 13F reported holding 1.35 million shares of the company. Israel Englander‘s Millennium Management has been bullish on the company during the October-December period and raised its position by 24% to around 412,200 shares. On the other hand, Jim Simons‘ Renaissance Technologies has reduced slightly its holding to 340,400 shares.

In a separate filing, Coliseum Capital disclosed holding 2,065 units of The Providence Service Corporation (NASDAQ:PRSC)’s Phantom Stock. As of the end of the fourth quarter of 2013, the fund held 2.32 million shares of The Providence Service Corporation.

For the fourth quarter of 2013, The Providence Service Corporation reported net income of $3.4 million, or $0.24 per share, up 17% from $2.9 million, or $0.22 per share, in the prior year period. For the full year of 2013, the company’s net income was $19.4 million, or $1.41 per share, in 2013, a 129% and 120% increase, respectively, from $8.5 million, or $0.64 per share, in 2012.

Renaissance Technologies is also a shareholder of The Providence Service Corporation, holding 816,000 shares as at the end of last year.

Coliseum Capital is an activist hedge fund founded by Christopher Shackelton and Adam Gray. The fund owns 2.56 million shares of LHC Group Inc. (NASDAQ:LHCG), which is the most valuable holding in the fund’s equity portfolio (worth $61.63 million). In December 2013, Coliseum Capital acquired 24,700 shares of Accuride Corporation (NYSE:ACW) in one transaction at a price of $3.38 apiece, bringing the fund’s stake to little over 8.2 million shares.

Disclosure: none

Recommended reading:

Relational Investors Sell Some Shares of SPX Corporation (SPW)

Hal Mintz, Sabby Management Report 7.43% Stake in Oxygen Biotherapeutics, Inc. (OXBT)

Cove Street Capital Ups Stake in Signature Group Holdings, Inc (SGGH)

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!